key: cord-0854730-pxownnv7 authors: Fernández-de-las-Peñas, César; Florencio, Lidiane L.; Gómez-Mayordomo, Víctor; Cuadrado, María L.; Palacios-Ceña, Domingo; Raveendran, Arkiath Veettil title: Proposed integrative model for post-COVID symptoms date: 2021-06-01 journal: Diabetes Metab Syndr DOI: 10.1016/j.dsx.2021.05.032 sha: d6e7ca1614c77eed446c233cdb7307c4013ca9a4 doc_id: 854730 cord_uid: pxownnv7 BACKGROUND AND AIMS: To propose an integrative model for post-COVID symptoms by considering the absence/presence of previous symptomatology. METHODS: We searched different databases for original articles and reviews on post-COVID symptoms. RESULTS: The first consideration is to define which symptoms are of “new-onset” (symptoms never experienced by a patient before COVID-19 and experienced the first time after) and which symptoms are “exacerbated” (symptoms experienced by a patient prior to COVID-19 but aggravated later) after infection. The second consideration includes defining “persistent” (symptoms experienced at the acute phase and continuing after without remission period) and “delayed-onset” (symptoms not experienced at the acute phase of the infection but appearing after a “latency period”). This model integrates predisposing individual factors, biological factors associated to the severity of disease, hospitalization/treatment factors, and outbreak surrounding factors which may promote post-COVID. CONCLUSION: Since current literature on post-COVID is heterogeneous, this integrative model could help to a better characterization of long-COVID. The presence of sequelae after coronavirus disease 2019 (COVID-19) has provoked a unexpected second pandemic, the "long-haulers" i.e., individuals suffering from post-COVID symptoms (long-COVID). 1 The term long-COVID is probably the first medical disease term firstly promoted by the patients themselves. 2 In fact, the term long-COVID is now recognized by the World Health Organization (WHO) as a worldwide health care problem and an "emergency-use" ICD code has been assigned (U09.9 Post-COVID). 3 Long-COVID is a term generally used for describing individuals who had recovered from COVID-19, but they continue exhibiting associated-symptoms after the acute phase, once the infection has been theoretically ceased. 4 No consensus in post-COVID terminology exists. 5 Some authors have discussed the topic if these symptoms should be associated or not with a positive diagnosis 6,7 and also potential timeframes 8,9 for considering the term "post-acute" or "long-COVID". Nevertheless, a discussion about the different scenarios in relation to the development of post-COVID symptoms is scarce. It seems that 80% of COVID-19 survivors could exhibit post-COVID symptoms after surpassing the acute phase of the infection. 10 A recent meta-analysis, published as a preprint, has reported that fatigue, headache, and attention disorders are the top three post-COVID symptoms. 11 However, the heterogeneity in the presentation of these symptoms supports the priority of better phenotyping and defining post-COVID. Therefore, this paper aims to propose an integrative model by considering different classifications, based on the absence or presence of previous symptomatology and the presence or absence of a remission/delayed period. The first consideration is based on the previous presence/experience of a symptom. Therefore, the first step is to identify if a particular post-COVID symptom The second consideration is the moment when the symptom appears in relation to the acute phase of infection. We define "persistent post-COVID" as a symptom experienced by a patient at the acute phase of the infection (e.g., headache, myalgia) which does not disappear at any time after (post-COVID). It would be a patient experiencing headache as symptom during the acute COVID-19 phase and that persists after COVID-19 without interruption, e.g., fulfilling pattern of new-daily persistent headache. We define "delayed-onset post-COVID" as a symptom not experienced by a patient at the acute COVID-19 phase but appearing after a latency period (post-COVID). For instance, a patient who has not experienced e.g., headache as a symptom at the acute phase of infection but it appears several days or weeks after resolution of the infection, e.g., fulfilling pattern of migraine-like headache. Increasing evidence supports that COVID-19 onset symptoms may influence the development of post-COVID symptomatology. For example, the presence of multiple symptoms such as cough, shortness of breath, headache, diarrhea, and hoarseness of voice at COVID-19 onset has been associated with a higher risk of long-COVID J o u r n a l P r e -p r o o f The lasting misery of coronavirus long-haulers Emergency use ICD codes for COVID-19 disease outbreak How to define it and how to manage it Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria Long COVID: An overview Defining post-COVID symptoms (Post-acute COVID, long COVID, persistent Post-COVID): An integrative classification A Proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications Post-acute COVID-19 syndrome More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv Research priorities for Long COVID: refined through an international multi-stakeholder forum Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution Headache characteristics in COVID-19 pandemic-a survey study Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome COVID symptoms, symptom clusters, and predictors for becoming a longhauler: Looking for clarity in the haze of the pandemic. medRxiv Myalgia as a symptom at hospital admission by Sars-Cov-2 infection is associated to persistent musculoskeletal pain as long-term post-covid sequelae: A case-control study